# Emergent BioSolutions Inc.: Form 8-K, filed May 29, 2024

- Company: [Emergent BioSolutions Inc.](/companies/ebs.md) (CIK 1367644)
- Form: 8-K
- Filed: 2024-05-29
- Accepted by EDGAR: May 29, 2024, 07:34 ET
- Period: 2024-05-23
- Accession: 0001367644-24-000093
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1367644/000136764424000093/ebs-20240523.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1367644/000136764424000093/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1367644/000136764424000093/ebs-20240523.htm

Filed May 29, 2024.
Source: SEC EDGAR, the filing index for accession 0001367644-24-000093. Last ingested by Listed: Nov 4, 2026, 16:51 ET. No prices; not investment advice.
